Literature DB >> 19716989

First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives.

Joanna J Arch1, Michelle G Craske.   

Abstract

In this article, the authors assess the successes, remaining challenges, and new developments in cognitive behavioral therapy (CBT) for anxiety disorders. They define CBT, examine treatment components, review treatment efficacy, and discuss the challenges of attrition, long-term follow-up, co-occurring/comorbid disorders, limited treatment comparisons, treatment mediators, and broader implementation. In addition, they present recent developments in cognitive behavioral therapy for anxiety disorders, including linking exposure therapy to basic science, mindfulness and acceptance-based treatments, and unified or transdiagnostic treatment protocols.

Entities:  

Mesh:

Year:  2009        PMID: 19716989     DOI: 10.1016/j.psc.2009.05.001

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  34 in total

1.  Anxiety interventions delivered in primary care behavioral health routine clinical practice.

Authors:  Robyn L Shepardson; Mark R Minnick; Jennifer S Funderburk
Journal:  Fam Syst Health       Date:  2020-06       Impact factor: 1.950

2.  Does prior traumatization affect the treatment outcome of CBT for panic disorder? The potential role of the MAOA gene and depression symptoms.

Authors:  Sebastian Trautmann; Jan Richter; Markus Muehlhan; Michael Höfler; Hans-Ulrich Wittchen; Katharina Domschke; Andreas Ströhle; Alfons O Hamm; Heike Weber; Tilo Kircher; Volker Arolt; Alexander L Gerlach; Georg W Alpers; Thomas Fydrich; Thomas Lang; Andreas Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-15       Impact factor: 5.270

3.  Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia.

Authors:  A T Gloster; H U Wittchen; F Einsle; M Höfler; T Lang; S Helbig-Lang; T Fydrich; L Fehm; A O Hamm; J Richter; G W Alpers; A L Gerlach; A Ströhle; T Kircher; J Deckert; P Zwanzger; V Arolt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

4.  Error-related Brain Activity as a Treatment Moderator and Index of Symptom Change during Cognitive-Behavioral Therapy or Selective Serotonin Reuptake Inhibitors.

Authors:  Stephanie M Gorka; Katie L Burkhouse; Heide Klumpp; Amy E Kennedy; Kaveh Afshar; Jennifer Francis; Olusola Ajilore; Scott Mariouw; Michelle G Craske; Scott Langenecker; Stewart A Shankman; K Luan Phan
Journal:  Neuropsychopharmacology       Date:  2017-11-28       Impact factor: 7.853

Review 5.  Using model systems to understand errant plasticity mechanisms in psychiatric disorders.

Authors:  Bruno B Averbeck; Matthew V Chafee
Journal:  Nat Neurosci       Date:  2016-10-26       Impact factor: 24.884

6.  Reenvisioning Clinical Science: Unifying the Discipline to Improve the Public Health.

Authors:  Lisa S Onken; Kathleen M Carroll; Varda Shoham; Bruce N Cuthbert; Melissa Riddle
Journal:  Clin Psychol Sci       Date:  2014-01-01

7.  Distinct neural engagement during implicit and explicit regulation of negative stimuli.

Authors:  Jacklynn M Fitzgerald; Kerry L Kinney; K Luan Phan; Heide Klumpp
Journal:  Neuropsychologia       Date:  2018-02-08       Impact factor: 3.139

8.  Maximizing exposure therapy: an inhibitory learning approach.

Authors:  Michelle G Craske; Michael Treanor; Christopher C Conway; Tomislav Zbozinek; Bram Vervliet
Journal:  Behav Res Ther       Date:  2014-05-09

9.  Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety.

Authors:  Yuko Hakamata; Shmuel Lissek; Yair Bar-Haim; Jennifer C Britton; Nathan A Fox; Ellen Leibenluft; Monique Ernst; Daniel S Pine
Journal:  Biol Psychiatry       Date:  2010-12-01       Impact factor: 13.382

10.  Chronic environmental stress and the temporal course of depression and panic disorder: A trait-state-occasion modeling approach.

Authors:  Christopher C Conway; Lauren A Rutter; Timothy A Brown
Journal:  J Abnorm Psychol       Date:  2015-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.